ResearcherCedars-Sinai Medical CenterActive in the last 2 years
Abrahm Levi
Matched on ORCID iD 0009-0005-3074-6166; OpenAlex author ID A5058983441. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 5
- Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. Co-author DOI 10.1002/pon.70601↗
- Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directed care. Co-author DOI 10.1016/j.hpb.2025.07.012↗
- Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database. Co-author DOI 10.1093/oncolo/oyaf007↗
- Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort Study. Co-author DOI 10.14309/ctg.0000000000000719↗
- Combination L-Glutamine with Gemcitabine and Nab-Paclitaxel in Treatment-Naïve Advanced Pancreatic Cancer: The Phase I GlutaPanc Study Protocol. Co-author DOI 10.3390/biomedicines11051392↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew Eugene Hendifar · 5 shared papers, 2023–2026 · strength 1.01
- Paper Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. DOI 10.1002/pon.70601↗
- Paper Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort… DOI 10.14309/ctg.0000000000000719↗
- Paper Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from … DOI 10.1093/oncolo/oyaf007↗
- Jun Gong · 5 shared papers, 2023–2026 · strength 1.01
- Paper Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. DOI 10.1002/pon.70601↗
- Paper Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort… DOI 10.14309/ctg.0000000000000719↗
- Paper Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from … DOI 10.1093/oncolo/oyaf007↗
- Arsen Osipov · 5 shared papers, 2023–2026 · strength 1.01
- Paper Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. DOI 10.1002/pon.70601↗
- Paper Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort… DOI 10.14309/ctg.0000000000000719↗
- Paper Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from … DOI 10.1093/oncolo/oyaf007↗
- Simon K. Lo · 3 shared papers, 2024–2026 · strength 0.64
- Paper Young Women With Pancreatic Cancer: A High-Risk Group for Demoralization. DOI 10.1002/pon.70601↗
- Paper Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort… DOI 10.14309/ctg.0000000000000719↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Srinivas Gaddam · 2 shared papers, 2025–2026 · strength 0.44
- Nicholas N. Nissen · 2 shared papers, 2024–2025 · strength 0.39
- Paper Ascites Is a Poor Prognostic Factor in Advanced Pancreatic Adenocarcinoma and May Be Undertreated: A Prospective Cohort… DOI 10.14309/ctg.0000000000000719↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Matthew Ebia · 2 shared papers, 2025 · strength 0.39
- Paper Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from … DOI 10.1093/oncolo/oyaf007↗
- Paper Enhancing management of pancreatic cancer: impact of a same day multidisciplinary clinic on access to guideline-directe… DOI 10.1016/j.hpb.2025.07.012↗
- Andrew L. Coveler · 1 shared paper, 2026 · strength 0.25
- Brian T. Anderson · 1 shared paper, 2026 · strength 0.25
- Justin Wang · 1 shared paper, 2024 · strength 0.21
- Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.21
- Rachna T. Shroff · 1 shared paper, 2025 · strength 0.20
- Emanuel F. Petricoin · 1 shared paper, 2025 · strength 0.20
- Jennifer W. Chuy · 1 shared paper, 2025 · strength 0.20
- Raymond Couric Wadlow · 1 shared paper, 2025 · strength 0.20
- Lei Zheng · 1 shared paper, 2025 · strength 0.20
- Michael Jon Pishvaian · 1 shared paper, 2025 · strength 0.20
- Gillian K. Gresham · 1 shared paper, 2025 · strength 0.20
- Lynn McCormick Matrisian · 1 shared paper, 2025 · strength 0.20
- Brent K. Larson · 1 shared paper, 2025 · strength 0.19
- Alexandra Gangi · 1 shared paper, 2025 · strength 0.19
- Mitchell R. Kamrava · 1 shared paper, 2025 · strength 0.19
- Cristina Rosa Ferrone · 1 shared paper, 2025 · strength 0.19
- Neil A. Bhowmick · 1 shared paper, 2023 · strength 0.16
- Hayato Muranaka · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.